Ekawalishyam Hospitals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-12-2024
- Paid Up Capital ₹ 0.78 M
as on 24-12-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.70 M
as on 24-12-2024
- Revenue 2.00%
(FY 2020)
- Profit 148.29%
(FY 2020)
- Ebitda 90.58%
(FY 2020)
- Net Worth 14.49%
(FY 2020)
- Total Assets 18.27%
(FY 2020)
About Ekawalishyam Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.78 M.
The company has closed loans amounting to ₹0.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kumar Singh, Vishal Ranjan, and Urmila Thakur serve as directors at the Company.
- CIN/LLPIN
U85110BR2004PTC010676
- Company No.
010676
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Apr 2004
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- LocationSiwan, Bihar
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ekawalishyam Hospitals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kumar Singh  | Director | 02-Apr-2004 | Current |
| Vishal Ranjan | Director | 04-Feb-2015 | Current |
| Urmila Thakur | Director | 02-Apr-2004 | Current |
Financial Performance of Ekawalishyam Hospitals.
Ekawalishyam Hospitals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2% increase. The company also saw a substantial improvement in profitability, with a 148.29% increase in profit. The company's net worth Soared by an impressive increase of 14.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ekawalishyam Hospitals?
In 2020, Ekawalishyam Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanjeewani Drug And Diagnostics Private LimitedActive 20 years 3 monthsKumar Singh, Vishal Ranjan and 1 more are mutual person
- Urmila Automobiles Private LimitedActive 7 years 4 months
Kumar Singh and Urmila Thakur are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 26 Jun 2008 | ₹0.70 M | Satisfied |
How Many Employees Work at Ekawalishyam Hospitals?
Unlock and access historical data on people associated with Ekawalishyam Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ekawalishyam Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ekawalishyam Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
